Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study

scientific article published on 16 October 2015

Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4143/CRT.2015.226
P932PMC publication ID4946358
P698PubMed publication ID26511805
P5875ResearchGate publication ID283237011

P50authorYung-Jue BangQ16180903
Eui Kyu ChieQ44335316
Seock-Ah ImQ58821370
Kyubo KimQ87569611
Do-Youn OhQ87569618
Tae-You KimQ87569625
Kyung Hun LeeQ87845591
Sae-Won HanQ91404079
Younak ChoiQ117206995
P2093author name stringTae-Yong Kim
Sung Whan Ha
P2860cites workAnalysis of mortality rates for pancreatic cancer across the worldQ24646766
Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled studyQ33349410
Salvage chemoradiotherapy after primary chemotherapy for locally advanced pancreatic cancer: a single-institution retrospective analysisQ34518978
Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trialQ36476666
Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.Q36751555
A comparison of three treatment strategies for locally advanced and borderline resectable pancreatic cancerQ36792356
Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer--a multi-centre raQ37457763
Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?Q43960823
Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junctionQ44908374
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results ofQ46604466
A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282.Q46608868
Clinical cancer advances 2010: annual report on progress against cancer from the American Society of Clinical OncologyQ48766509
Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III StudiesQ57758319
Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study GroupQ69919858
Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group studyQ70062032
Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor StudyQ70937645
Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapyQ80407725
Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysisQ84100587
Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trialQ86800667
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P433issue3
P921main subjectchemoradiotherapyQ5090613
pancreatic cancerQ212961
chemotherapyQ974135
P304page(s)1045-1055
P577publication date2015-10-16
P1433published inCancer Research and TreatmentQ18411021
P1476titleConcurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study
P478volume48

Reverse relations

cites work (P2860)
Q38801235Change in carbohydrate antigen 19-9 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapy
Q40506490Risk factors for latent distant organ metastasis detected by staging laparoscopy in patients with radiologically defined locally advanced pancreatic ductal adenocarcinoma
Q33868592Risk factors of liver metastasis from advanced pancreatic adenocarcinoma: a large multicenter cohort study
Q91771819Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer

Search more.